Followed by the battle of impotency treatments, Pfizer and Hanmi will take a battle over antismoking products

Pfizer Korea and Hanmi Pharmaceutical will take a 4-round battle for their major product.

Hanmi Pharmaceutical, which defeated the original of a impotency drug, ‘Viagra’, with its generic, ‘Palpal’, is now looking forward to see a chance to defeat the top antismoking product with its follow-up product.

Unfortunately, its competitor is Pfizer, again. ‘Nicopion (bupropion)’, an antismoking prod...